Rosanne Janssens

913 total citations
35 papers, 521 citations indexed

About

Rosanne Janssens is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rosanne Janssens has authored 35 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 8 papers in General Health Professions and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rosanne Janssens's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Patient-Provider Communication in Healthcare (7 papers) and Pharmaceutical Economics and Policy (6 papers). Rosanne Janssens is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Patient-Provider Communication in Healthcare (7 papers) and Pharmaceutical Economics and Policy (6 papers). Rosanne Janssens collaborates with scholars based in Belgium, United States and Netherlands. Rosanne Janssens's co-authors include Isabelle Huys, Gregory Absillis, Tatjana N. Parac‐Vogt, Paul Proost, Hong Giang T. Ly, Jorien Veldwijk, Esther W. de Bekker‐Grob, Steven Simoens, Eline van Overbeeke and Irina Cleemput and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rosanne Janssens

30 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosanne Janssens Belgium 13 170 112 96 59 54 35 521
David Pérez New Zealand 19 79 0.5× 90 0.8× 17 0.2× 104 1.8× 38 0.7× 60 1.1k
Christine Kubiak France 10 107 0.6× 52 0.5× 23 0.2× 140 2.4× 3 0.1× 27 463
Mark Price United States 17 41 0.2× 30 0.3× 23 0.2× 37 0.6× 8 0.1× 59 729
Nicholas J. Seewald United States 9 30 0.2× 101 0.9× 12 0.1× 26 0.4× 25 0.5× 17 423
Catherine McGrath United Kingdom 16 21 0.1× 54 0.5× 121 1.3× 33 0.6× 64 1.2× 39 635
Zhenzhong Zhang China 11 28 0.2× 48 0.4× 32 0.3× 25 0.4× 14 0.3× 23 315
Sarah Stallings United States 13 39 0.2× 108 1.0× 6 0.1× 94 1.6× 9 0.2× 28 399
Christopher Lawrence United Kingdom 12 65 0.4× 46 0.4× 16 0.2× 89 1.5× 16 0.3× 26 563
Rong Fu China 14 31 0.2× 99 0.9× 23 0.2× 31 0.5× 76 552

Countries citing papers authored by Rosanne Janssens

Since Specialization
Citations

This map shows the geographic impact of Rosanne Janssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosanne Janssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosanne Janssens more than expected).

Fields of papers citing papers by Rosanne Janssens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosanne Janssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosanne Janssens. The network helps show where Rosanne Janssens may publish in the future.

Co-authorship network of co-authors of Rosanne Janssens

This figure shows the co-authorship network connecting the top 25 collaborators of Rosanne Janssens. A scholar is included among the top collaborators of Rosanne Janssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosanne Janssens. Rosanne Janssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morgan, Kate, Ariel Aviv, Varda Shoham, et al.. (2025). Patients and healthcare professionals’ perspectives on the implementation of shared decision making in multiple myeloma: a multinational qualitative study. BMC Medical Informatics and Decision Making. 25(1). 432–432.
3.
4.
Simoens, Steven, Walter Van Dyck, Rosanne Janssens, Liese Barbier, & Jeroen Luyten. (2025). Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences. Applied Health Economics and Health Policy. 23(4). 613–624. 1 indexed citations
5.
Outtier, An, Rosanne Janssens, Liese Barbier, et al.. (2024). Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis. United European Gastroenterology Journal. 13(4). 542–551. 2 indexed citations
6.
Barbier, Liese, Walter Droogné, Peter Sinnaeve, et al.. (2024). Heart Failure Patients' Perspectives on Treatment Outcomes and Unmet Medical Needs: A Qualitative Preference Study. ESC Heart Failure. 11(5). 3075–3084. 1 indexed citations
7.
Broekmans, J. F., Rosanne Janssens, Liese Barbier, et al.. (2024). Needs Examination, Evaluation and Dissemination (NEED): applicability to rare diseases. Lirias (KU Leuven). 1 indexed citations
8.
Janssens, Rosanne, Liese Barbier, Irina Cleemput, et al.. (2023). How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action. Frontiers in Pharmacology. 14. 1192770–1192770. 5 indexed citations
9.
Huys, Isabelle, et al.. (2023). Existing Meditation and Breathing Devices for Stress Reduction and Their Incorporated Stimuli: A Systematic Literature Review and Competition Analysis. SHILAP Revista de lepidopterología. 1(3). 395–405. 3 indexed citations
10.
Zimmeren, Esther van, Timo Minssen, Walter Van Dyck, et al.. (2022). Compulsory licensing for expensive medicines. 1 indexed citations
11.
Zimmeren, Esther van, Timo Minssen, Walter Van Dyck, et al.. (2022). Compulsory licensing for expensive medicines. 1 indexed citations
12.
Janssens, Rosanne, Serena Petrocchi, Serena Oliveri, et al.. (2021). Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy. Frontiers in Pharmacology. 12. 710518–710518. 6 indexed citations
13.
Petrocchi, Serena, Rosanne Janssens, Serena Oliveri, et al.. (2021). What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences. Frontiers in Pharmacology. 12. 602112–602112. 6 indexed citations
14.
Durosini, Ilaria, Rosanne Janssens, Jorien Veldwijk, et al.. (2021). Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients. Frontiers in Public Health. 9. 622154–622154. 12 indexed citations
15.
Janssens, Rosanne, Daniel Coriu, Maria-Elena Cabezudo, et al.. (2020). PCN297 Understanding What Matters to Multiple Myeloma Patients: A Qualitative Study. Value in Health. 23. S474–S475. 2 indexed citations
16.
Grine, Lynda, et al.. (2020). Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey. Frontiers in Medicine. 7. 36–36. 5 indexed citations
17.
Janssens, Rosanne, Isabelle Huys, Eline van Overbeeke, et al.. (2019). Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making. 19(1). 189–189. 37 indexed citations
18.
Overbeeke, Eline van, Chiara Whichello, Rosanne Janssens, et al.. (2018). Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today. 24(1). 57–68. 72 indexed citations
19.
Ly, Hong Giang T., Gregory Absillis, Rosanne Janssens, Paul Proost, & Tatjana N. Parac‐Vogt. (2015). Highly Amino Acid Selective Hydrolysis of Myoglobin at Aspartate Residues as Promoted by Zirconium(IV)‐Substituted Polyoxometalates. Angewandte Chemie International Edition. 54(25). 7391–7394. 100 indexed citations
20.
Jain, S.C., et al.. (1983). The effective lifetime in semicrystalline silicon. Solar Cells. 9(4). 345–352. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Pérez Breakdown of academic impact, for papers by Christine Kubiak Breakdown of academic impact, for papers by Mark Price Breakdown of academic impact, for papers by Nicholas J. Seewald Breakdown of academic impact, for papers by Catherine McGrath Breakdown of academic impact, for papers by Zhenzhong Zhang Breakdown of academic impact, for papers by Sarah Stallings Breakdown of academic impact, for papers by Christopher Lawrence Breakdown of academic impact, for papers by Rong Fu
Rankless by CCL
2026